Differences in Ovarian Cancer Cell Susceptibility to Immune Attack
Author Information
Author(s): D.A. Clark, H.W. Hirte, R.N. Buick
Primary Institution: McMaster University and The Ontario Cancer Institute
Hypothesis
Are there patient-related differences in the susceptibility of ovarian carcinoma cells to cytotoxic effectors?
Conclusion
The study found that different patients' ovarian carcinoma cells showed varying susceptibility to lysis by different immune effector cells.
Supporting Evidence
- Different tumour cell donors showed varying patterns of susceptibility to immune cell lysis.
- Interleukin 2-activated killer cells consistently killed the fractions containing clonogenic cells.
- Interferon activation shifted the killing pattern away from stem cells in some cases.
Takeaway
Some ovarian cancer cells are harder to kill than others, and this can change from patient to patient.
Methodology
The study used cryopreserved tumour cell preparations and tested their susceptibility to lysis by various immune cells.
Potential Biases
Potential bias due to the use of a single donor for effector cells.
Limitations
The study was limited to a small number of patients and may not represent all ovarian carcinoma cases.
Participant Demographics
Patients with ovarian carcinoma, specific demographics not detailed.
Want to read the original?
Access the complete publication on the publisher's website